Connor Clark & Lunn Investment Management Ltd. Has $353,000 Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Connor Clark & Lunn Investment Management Ltd. decreased its stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 66.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,898 shares of the company’s stock after selling 13,735 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Crinetics Pharmaceuticals were […]

Leave a Reply

Your email address will not be published.

Connor Clark & Lunn Investment Management Ltd. Has $353,000 Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Connor Clark & Lunn Investment Management Ltd. decreased its stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 66.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,898 shares of the company’s stock after selling 13,735 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Crinetics Pharmaceuticals were […]

Leave a Reply

Your email address will not be published.

Previous post Cibc World Markets Corp Takes Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Next post GCM Resources (LON:GCM) Trading Up 42.9% – Time to Buy?